Shares of the clinical-stage biotech Oramed Pharmaceuticals (NASDAQ: ORMP) are having a banner day today. Specifically, the company's stock price rose by as much as 40% on extremely high volume early on in Tuesday's trading session. The biotech's shares have cooled off as the day has progressed. But Oramed's stock was still up by a respectiable 16% as of 1:23 p.m ET Tuesday afternoon.
What's causing investors to rush into this small-cap biotech stock ? Oramed's shares have been racing higher ever since management released a letter to shareholders last Friday .
Image source: Getty Images.
For further details see:
Why Oramed Pharmaceuticals Stock Is On Fire Today